CMPX
Price
$3.00
Change
-$0.15 (-4.76%)
Updated
Jul 18 closing price
Capitalization
414.85M
10 days until earnings call
MGNX
Price
$1.48
Change
-$0.06 (-3.90%)
Updated
Jul 18 closing price
Capitalization
93.37M
23 days until earnings call
Interact to see
Advertisement

CMPX vs MGNX

Header iconCMPX vs MGNX Comparison
Open Charts CMPX vs MGNXBanner chart's image
Compass Therapeutics
Price$3.00
Change-$0.15 (-4.76%)
Volume$662.52K
Capitalization414.85M
MacroGenics
Price$1.48
Change-$0.06 (-3.90%)
Volume$381.88K
Capitalization93.37M
CMPX vs MGNX Comparison Chart in %
Loading...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMPX vs. MGNX commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMPX is a Hold and MGNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (CMPX: $3.00 vs. MGNX: $1.48)
Brand notoriety: CMPX and MGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMPX: 85% vs. MGNX: 26%
Market capitalization -- CMPX: $414.85M vs. MGNX: $93.37M
CMPX [@Biotechnology] is valued at $414.85M. MGNX’s [@Biotechnology] market capitalization is $93.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMPX’s FA Score shows that 0 FA rating(s) are green whileMGNX’s FA Score has 0 green FA rating(s).

  • CMPX’s FA Score: 0 green, 5 red.
  • MGNX’s FA Score: 0 green, 5 red.
According to our system of comparison, CMPX is a better buy in the long-term than MGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMPX’s TA Score shows that 4 TA indicator(s) are bullish while MGNX’s TA Score has 5 bullish TA indicator(s).

  • CMPX’s TA Score: 4 bullish, 4 bearish.
  • MGNX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MGNX is a better buy in the short-term than CMPX.

Price Growth

CMPX (@Biotechnology) experienced а +11.11% price change this week, while MGNX (@Biotechnology) price change was -8.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

CMPX is expected to report earnings on Jul 30, 2025.

MGNX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CMPX($415M) has a higher market cap than MGNX($93.4M). CMPX YTD gains are higher at: 106.897 vs. MGNX (-54.462). MGNX has higher annual earnings (EBITDA): -47.33M vs. CMPX (-60.17M). MGNX has more cash in the bank: 154M vs. CMPX (113M). CMPX has less debt than MGNX: CMPX (6.38M) vs MGNX (37.5M). MGNX has higher revenues than CMPX: MGNX (152M) vs CMPX (850K).
CMPXMGNXCMPX / MGNX
Capitalization415M93.4M444%
EBITDA-60.17M-47.33M127%
Gain YTD106.897-54.462-196%
P/E RatioN/AN/A-
Revenue850K152M1%
Total Cash113M154M73%
Total Debt6.38M37.5M17%
FUNDAMENTALS RATINGS
MGNX: Fundamental Ratings
MGNX
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CMPXMGNX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 24 days ago
89%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LOMLF0.220.01
+3.94%
Lion One Metals Ltd.
RHHBY40.080.20
+0.50%
Roche Holding Ltd
FIEB21.65N/A
N/A
First IC Corporation
WWNTF0.64N/A
N/A
Want Want China Holdings Ltd
HTROF2.25N/A
N/A
HEXATRONIC GROUP AB

CMPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMPX has been loosely correlated with VIR. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CMPX jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMPX
1D Price
Change %
CMPX100%
-4.76%
VIR - CMPX
39%
Loosely correlated
-1.46%
SANA - CMPX
36%
Loosely correlated
+4.04%
MGNX - CMPX
35%
Loosely correlated
-3.90%
CPRX - CMPX
35%
Loosely correlated
-1.96%
FHTX - CMPX
35%
Loosely correlated
+0.49%
More

MGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGNX has been loosely correlated with XNCR. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MGNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGNX
1D Price
Change %
MGNX100%
-3.90%
XNCR - MGNX
51%
Loosely correlated
-1.10%
CRBU - MGNX
51%
Loosely correlated
+12.02%
CRSP - MGNX
48%
Loosely correlated
+18.22%
BEAM - MGNX
48%
Loosely correlated
+1.47%
SYRE - MGNX
47%
Loosely correlated
-3.55%
More